New Guidance for Bioscience Startups The CARES Act was signed March 27th with the goal to inject liquidity into an American economy profoundl.....

Ask any of BioEnterprise's Executives-in-Residence what makes starting a bioscience business so different from other startups, and you’ll likely hear .....

Cleveland has long been at the forefront of an industry gaining new traction as an effective and drug-free pain remedy: neuromodulation. Neuromodul.....

It is critically important to have a robust commercialization strategy in order to develop and sell a new medical device or diagnostic product to hospitals. In this session, experienced industry professionals and specialized consultants will discuss the critical elements that need to be addressed, including the importance of claims to support regulatory requirements and marketing and sales objectives.